BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18411709)

  • 41. Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review.
    Adegbola MA
    Biol Res Nurs; 2009 Jul; 11(1):81-97. PubMed ID: 19487302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human expression variation in the mu-opioid receptor is paralleled in rhesus macaque.
    Vallender EJ; Priddy CM; Chen GL; Miller GM
    Behav Genet; 2008 Jul; 38(4):390-5. PubMed ID: 18379868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene expression is altered in the lateral hypothalamus upon activation of the mu opioid receptor.
    Befort K; Filliol D; Darcq E; Ghate A; Matifas A; Lardenois A; Muller J; Thibault C; Dembele D; Poch O; Kieffer BL
    Ann N Y Acad Sci; 2008; 1129():175-84. PubMed ID: 18591478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. mu-Opioid agonists inhibit the enhanced intracellular Ca(2+) responses in inflammatory activated astrocytes co-cultured with brain endothelial cells.
    Hansson E; Westerlund A; Björklund U; Olsson T
    Neuroscience; 2008 Sep; 155(4):1237-49. PubMed ID: 18692967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Molecular mechanisms of the brain reward system].
    Ikeda K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):263-6. PubMed ID: 22256617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid pharmacology.
    Trescot AM; Datta S; Lee M; Hansen H
    Pain Physician; 2008 Mar; 11(2 Suppl):S133-53. PubMed ID: 18443637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serotonin receptor gene polymorphism and analgesic sensitivity].
    Aoki J; Ikeda K; Iwahashi K
    Masui; 2009 Sep; 58(9):1130-5. PubMed ID: 19764436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of opioid-mediated inhibition of human T cell receptor signaling.
    Börner C; Warnick B; Smida M; Hartig R; Lindquist JA; Schraven B; Höllt V; Kraus J
    J Immunol; 2009 Jul; 183(2):882-9. PubMed ID: 19561113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetics of pain, opioids, and opioid responsiveness.
    Tremblay J; Hamet P
    Metabolism; 2010 Oct; 59 Suppl 1():S5-8. PubMed ID: 20837195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripherally-acting opioids.
    Smith HS
    Pain Physician; 2008 Mar; 11(2 Suppl):S121-32. PubMed ID: 18443636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options.
    Porreca F; Ossipov MH
    Pain Med; 2009; 10(4):654-62. PubMed ID: 19302436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pro-nociceptive effects of remifentanil or surgical injury in mice are associated with a decrease in delta-opioid receptor mRNA levels: Prevention of the nociceptive response by on-site delivery of enkephalins.
    Cabañero D; Célérier E; García-Nogales P; Mata M; Roques BP; Maldonado R; Puig MM
    Pain; 2009 Jan; 141(1-2):88-96. PubMed ID: 19058913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential regulation of morphine antinociceptive effects by endogenous enkephalinergic system in the forebrain of mice.
    Chen TC; Cheng YY; Sun WZ; Shyu BC
    Mol Pain; 2008 Sep; 4():41. PubMed ID: 18826595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Genetic polymorphisms and opioid therapies].
    Landau R
    Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioids for intractable pain: the good, the bad and the ugly.
    Gallagher RM
    Pain Med; 2005; 6(2):103-4. PubMed ID: 15773872
    [No Abstract]   [Full Text] [Related]  

  • 57. [Non-opioid and opioid medication in neuropathic pain].
    Uyar M; Eyigör C
    Agri; 2008 Oct; 20(4):6-16. PubMed ID: 19117151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Considerations on the use of oxymorphone in geriatric patients.
    Pergolizzi JV; Raffa RB; Gould E
    Expert Opin Drug Saf; 2009 Sep; 8(5):603-13. PubMed ID: 19614559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacodynamics of pain perception and polymorphism].
    Kikuchi H
    Masui; 2009 Sep; 58(9):1084-5. PubMed ID: 19764429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of kappa-opioid receptors in visceral nociception in mice.
    Larsson MH; Bayati A; Lindström E; Larsson H
    Neurogastroenterol Motil; 2008 Oct; 20(10):1157-64. PubMed ID: 18643891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.